Walker reporting disclosures

Effective as of: November 30, 2022

In November 2007, a UK advisory group led by Sir David Walker published the Walker Guidelines for Disclosure and Transparency in Private Equity, which make recommendations to encourage greater disclosure and transparency by private equity firms investing in United Kingdom portfolio companies. Palamon Capital Partners (“Palamon”) has voluntarily agreed to endeavour to conform on a “comply or explain” basis as part of its support of the Walker Guidelines. Palamon also intends to work alongside its United Kingdom portfolio companies covered by the Walker Guidelines to do the same.

Palamon has published this document in order to provide information on its UK private equity operations as part of its ongoing commitment to compliance with the Guidelines.

Palamon’s Private Equity Operations
Palamon Capital Partners, LP is an independent private equity partnership founded in 1999, which is focused on providing equity for European growing asset-light service companies, investing across tech-enabled financial services, tech-enabled B2B & healthcare and consumer & education. The Firm has invested a total of €2.5 billion of capital from Funds and Co-investors, across 12 European countries in 43 companies.  Palamon originates, executes and manages investments on a pan-European basis, with a particular focus on the UK, Germany, Benelux, Italy, Spain, Norway, and Sweden. The Firm targets investments in companies where it can be the lead, or joint lead, private equity provider and where it can provide strategic direction and partner with management and entrepreneurs to help build equity value.  Palamon targets an average holding period of 5 to 7 years for investments but has extended the hold period out for as long as 14 years for situations with the capacity for extraordinary growth.

For more information on our investment approach and private equity operations, please see our website.

For more information on our structure and investment approach and how we deal with conflicts of interest see our website.

Palamon Capital Partners, LP is a limited partnership registered in Scotland and authorised and regulated by the UK Financial Services Authority. It currently manages three private equity investment funds, which are structured as limited partnerships: Palamon European Equity II, L.P.  and Palamon European Equity III, L.P. Palamon Capital Partners, LP operates out of a single office in London with its General Partner being Palamon Capital Partners, LLP (Virginia registered partnership) which is managed and operated by its partners.

Portfolio Companies
As of the date of this document, Palamon has one investment that qualifies as a portfolio company under the Guidelines. IDH Group is the largest dental services provider in the UK with over 540 practices.  Palamon first acquired Associated Dental Practices in 2009 and in 2011, in partnership with The Carlyle Group, acquired and merged it with IDH to create the market leader.  In 2021, Palamon purchased The Carlyle Group’s position in IDH and is now the majority controller of the company. For more information see our website.

Conflicts of Interest
Palamon places significant importance on the prevention and management of conflicts of interest and has established and implemented a formal conflicts policy which ensures that it has appropriate systems and controls in place to identify, prevent and manage conflicts between its own interests and those of its clients and those of one client and another.

Palamon Team and Leadership
Palamon has a team of investment, operating and group professionals located in London that manage Palamon’s investment activities across Europe. For more information on the team, please see our website

Limited Partners
With total capital committed to our Funds to date of €1.5bn we are supported by a range of institutional investors from around the world.  The current make-up of our investors base is as follows:

Commitment to the Walker Guidelines
Palamon is supportive of the Walker Guidelines and endeavours to conform to the Walker Guidelines on a “comply or explain” basis and intends to work alongside our United Kingdom portfolio companies covered by the Walker Guidelines to do the same.